Back | Next |
home / stock / cyrx / cyrx message board
Subject | By | Source | When |
---|---|---|---|
Houston again, partnering with Takeda's BioLife Plasma Services | H2R | investorshub | 09/08/2022 3:49:29 PM |
Two US Based Global Supply Chain Centers, Houston | H2R | investorshub | 08/07/2022 12:22:20 AM |
Belgium Cell Matters acquisition | H2R | investorshub | 08/07/2022 12:18:52 AM |
$CYRX Funnel Estimates | H2R | investorshub | 08/05/2022 1:18:05 AM |
$CYRX Growth by Region | H2R | investorshub | 08/05/2022 1:17:11 AM |
$CYRX Clinical Trial Funnel | H2R | investorshub | 08/05/2022 1:16:19 AM |
$CYRX: Earnings Call Aug 4th: | H2R | investorshub | 08/03/2022 1:14:16 AM |
Bought more shares today. | H2R | investorshub | 05/06/2022 2:01:24 PM |
$CYRX Growth in 2 images - May 2022 | H2R | investorshub | 05/06/2022 2:00:35 PM |
Commercial Outlook - May 2022 | H2R | investorshub | 05/06/2022 1:58:20 PM |
Q1 Earning on 05/05/2022 - Confirmed. | H2R | investorshub | 05/04/2022 2:50:00 PM |
Bought more in the $22, so not completely | H2R | investorshub | 05/02/2022 5:41:43 PM |
Cell&Co BioServices acquisition: growth strategy. | H2R | investorshub | 04/19/2022 6:15:27 PM |
SA Article, another Bullish Analysis | H2R | investorshub | 04/15/2022 8:25:20 PM |
$CYRX at the Disruptive Biotech Enabling Technologies Mini | H2R | investorshub | 04/07/2022 7:52:25 PM |
SA Article | H2R | investorshub | 04/01/2022 9:08:19 PM |
New Prague facility returns to full production after fire | H2R | investorshub | 03/30/2022 10:23:02 PM |
Gap up followed by a nice 9% move | H2R | investorshub | 03/29/2022 7:40:21 PM |
Board's confidence in business model and outlook | H2R | investorshub | 03/15/2022 6:47:01 PM |
$100M Repurchase Program | H2R | investorshub | 03/15/2022 6:44:02 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-03-15 11:30:03 ET UBS analyst issues BUY recommendation for CYRX on March 15, 2024 10:00AM ET. The previous analyst recommendation was Buy. CYRX was trading at $15.21 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst re...
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Thursday. Shares of Build-A-Bear Workshop, Inc. (NYSE: BBW) rose ...
Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire FY 2023 revenue of $233.3 million , in-line with guidance Year-over-year, Commercial Cell & Gene Therapy revenue rose 33%; BioStorage/BioServices revenue increased 45% Gl...